BDBM370195 US10233188, Example 82::US10800783, Example 82

SMILES: Cn1cc(cn1)S(=O)(=O)N1CCC(CC1)Nc1ncc2ccc(=O)n([C@@H]3CCC[C@@]3(C)O)c2n1

InChI Key: InChIKey=GPNPQTRGIAJGBJ-XMSQKQJNSA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 370195   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
CDK2/CycE (Homo sapiens (Human))	BDBM370195 (US10233188, Example 82 | US10800783, Example 82) Show SMILES Cn1cc(cn1)S(=O)(=O)N1CCC(CC1)Nc1ncc2ccc(=O)n([C@@H]3CCC[C@@]3(C)O)c2n1 |r| Show InChI InChI=1S/C22H29N7O4S/c1-22(31)9-3-4-18(22)29-19(30)6-5-15-12-23-21(26-20(15)29)25-16-7-10-28(11-8-16)34(32,33)17-13-24-27(2)14-17/h5-6,12-14,16,18,31H,3-4,7-11H2,1-2H3,(H,23,25,26)/t18-,22-/m1/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. US Patent					Assay Description The purpose of the CDK2/Cyclin E1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a flu...				US Patent US10800783 (2020)
					More data for this Ligand-Target Pair
CDK2/CycE (Homo sapiens (Human))	BDBM370195 (US10233188, Example 82 | US10800783, Example 82) Show SMILES Cn1cc(cn1)S(=O)(=O)N1CCC(CC1)Nc1ncc2ccc(=O)n([C@@H]3CCC[C@@]3(C)O)c2n1 |r| Show InChI InChI=1S/C22H29N7O4S/c1-22(31)9-3-4-18(22)29-19(30)6-5-15-12-23-21(26-20(15)29)25-16-7-10-28(11-8-16)34(32,33)17-13-24-27(2)14-17/h5-6,12-14,16,18,31H,3-4,7-11H2,1-2H3,(H,23,25,26)/t18-,22-/m1/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
CNRS					Assay Description The purpose of the CDK2/Cyclin E1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a flu...				J Med Chem 45: 1477-86 (2002) BindingDB Entry DOI: 10.7270/Q2FX7CSG
					More data for this Ligand-Target Pair
CDK6/Cyclin D1 (Homo sapiens (Human)-Mus musculus (mouse))	BDBM370195 (US10233188, Example 82 | US10800783, Example 82) Show SMILES Cn1cc(cn1)S(=O)(=O)N1CCC(CC1)Nc1ncc2ccc(=O)n([C@@H]3CCC[C@@]3(C)O)c2n1 |r| Show InChI InChI=1S/C22H29N7O4S/c1-22(31)9-3-4-18(22)29-19(30)6-5-15-12-23-21(26-20(15)29)25-16-7-10-28(11-8-16)34(32,33)17-13-24-27(2)14-17/h5-6,12-14,16,18,31H,3-4,7-11H2,1-2H3,(H,23,25,26)/t18-,22-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.21	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. US Patent					Assay Description The purpose of the CDK6/Cyclin D1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) in the presence of small molecule inhibitor...				US Patent US10800783 (2020)
					More data for this Ligand-Target Pair
CDK6/Cyclin D1 (Homo sapiens (Human)-Mus musculus (mouse))	BDBM370195 (US10233188, Example 82 | US10800783, Example 82) Show SMILES Cn1cc(cn1)S(=O)(=O)N1CCC(CC1)Nc1ncc2ccc(=O)n([C@@H]3CCC[C@@]3(C)O)c2n1 |r| Show InChI InChI=1S/C22H29N7O4S/c1-22(31)9-3-4-18(22)29-19(30)6-5-15-12-23-21(26-20(15)29)25-16-7-10-28(11-8-16)34(32,33)17-13-24-27(2)14-17/h5-6,12-14,16,18,31H,3-4,7-11H2,1-2H3,(H,23,25,26)/t18-,22-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.21	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
CNRS					Assay Description The purpose of the CDK6/Cyclin D1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) in the presence of small molecule inhibitor...				J Med Chem 45: 1477-86 (2002) BindingDB Entry DOI: 10.7270/Q2FX7CSG
					More data for this Ligand-Target Pair